Table 3. Prevalence of drug-resistance mutations between the therapy-naïve (n = 94) and ART-failure population (n = 515) in the Yunnan province in 2010–2011.

Protease inhibitor			Nucleoside reverse transcriptase inhibitor			Non-nucleoside reverse transcriptase inhibitor
Mutations	Frequency (%)		Mutations	Frequency (%)		Mutations	Frequency (%)
	Naïve (n = 94)	ART-failure (n = 515)		Naïve (n = 94)	ART-failure (n = 515)		Naïve (n = 94)	ART-failure (n = 515)
L10F	0.0	0.6	M41L	0.0	3.7	A98G	0.0	2.1
V11I	0.0	1.0	K65R	0.0	0.2	K101Q	0.0	1.4
L23I	0.0	0.2	D67TG	0.0	0.8	K101E	0.0	3.7
D30N	1.1	0.0	D67N	0.0	3.9	K103N	0.0	19.2
L33F	0.0	1.2	T69D	0.0	1.0	K103R	0.0	2.9
M46IL	0.0	0.8	T69ins	1.1	0.0	V106A	0.0	22.1
Q58E	0.0	1.0	K70R	0.0	4.5	V106M	0.0	2.9
L76V	0.0	0.4	L74I	0.0	0.2	V108I	0.0	2.9
V82A	0.0	0.4	V75TAM	0.0	1.6	E138GQ	0.0	1.0
V82F	0.0	0.2	F116Y	0.0	0.2	Y181V	0.0	0.6
I84V	0.0	0.2	Q151M	0.0	0.6	Y181C	0.0	11.8
N88D	0.0	0.2	M184VI	0.0	28.2	Y188L	0.0	0.8
L90M	1.1	0.0	L210W	0.0	1.2	Y188C	0.0	0.8
			T215Y	0.0	2.7	Y188F	0.0	0.2
			T215F	0.0	4.1	G190S	0.0	0.6
			K219Q/E	0.0	5.1	G190A	0.0	12.4
						P225H	0.0	2.9
						F227L	0.0	1.2
						M230L	0.0	1.9
						K238T	0.0	1.0